Clinical Trial Update: OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating OPB-51602 in locally advanced nasopharyngeal carcinoma before definitive chemoradiotherapy; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• OPB-51602 (OPB-51602)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Nasopharyngeal Carcinoma | Phase 1 | Status: TERMINATED